
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Looking Beyond the Formulary Budget in Cost-Benefit Analysis
Author(s)Lawrence J. Cohen, PharmD
Advertisement
Articles in this issue
almost 29 years ago
Introduction: Looking Beyond the Formulary Budgetalmost 29 years ago
Evaluating the Cost Effectiveness of Newer Psychotropic Medicationsalmost 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomealmost 29 years ago
Newer Antipsychotic Medications: Discussionsalmost 29 years ago
Bibliographyalmost 29 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
5 Key Oncology FDA Approvals From November
5










































